Michael Douek

Michael Douek has a research interest in developing and evaluating novel techniques for cancer surgery. Besides a novel magnetic technique for sentinel node biopsy and lesion localization that he developed, he is one of the pioneers of intra-operative radiotherapy for breast cancer, high intensity focussed ultrasound (HIFU) for treating breast tumours and setup the first prospective trial of a biological device for breast implant reconstruction (POBRAD Trial of acellular dermal matrix for implant breast reconstruction). He is currently Chief Investigator of a number of international clinical trials inclucing the SentiMAG Multicentre Trial (first-in-woman trial of magnetic sentinel node biopsy in breast cancer), the MELAMAG Trial (first-in-man trial of magnetic sentinel node biopsy in melanoma) and of the POBRAD trial (prospective trial of acellular dermal matrix for implant breast reconstruction). He is also Principal Investigator for the international randomised controlled trial of intra-operative radiotherapy (TARGIT trial), at Guys Hospital.

In 2015, he was awarded a prestigious Hunterian Professorship by the Royal College of Surgeons of England.

Development and evaluation of novel devices and imaging modalities to improve cancer surgery. Clinical device trials.